Also trades as: NRSNW (NASDAQ) · $vol 0M
NRSN Earnings
NeuroSense Therapeutics Ltd.
1W: -42.5%
1M: -51.3%
3M: -71.3%
YTD: -74.4%
1Y: -83.9%
3Y: -72.6%
$3.94
-0.12 (-2.84%)
Weekly Expected Move ±25.0%
$2
$3
$4
$5
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-09-25
EPS
$-2.06
▲ Beat +47.2%
Revenue
$536K
Est (actual pending)
Next Earnings
Qtr ending 2026-12-30 · date TBD
EPS Estimate
$-0.20
Range: $-0.20 - $-0.20
Revenue Estimate
$278K
1 analysts
Estimate vs Actual
Earnings Surprise History
8/20
EPS Beats
0/20
Revenue Beats
40%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | annual | 2030-12-31 | $18.60 | $7.49 | ▼ 11.11 | $162,500,000 | $162,500,000 |
| 2026-09-29 | annual | 2027-12-31 | $-11.47 | $-10.31 | ▲ 1.16 | $3,277,900 | $3,277,900 |
| 2026-09-29 | annual | 2028-12-31 | $-13.60 | $-7.58 | ▲ 6.02 | $10,000,000 | $10,000,000 |
| 2026-09-29 | annual | 2026-12-31 | $-7.60 | $-6.62 | ▲ 0.98 | $714,067 | $714,067 |
| 2026-09-29 | quarter | 2026-12-31 | $-3.60 | $-3.17 | ▲ 0.43 | $278,500 | $278,500 |
| 2026-09-29 | annual | 2029-12-31 | $9.00 | $13.19 | ▲ 4.18 | $21,400,000 | $21,400,000 |
| 2026-09-15 | quarter | 2027-06-30 | $-0.23 | $-4.70 | ▼ 4.46 | $1,639,000 | $1,639,000 |
| 2026-09-15 | quarter | 2026-12-31 | $-0.18 | $-3.60 | ▼ 3.42 | $278,500 | $278,500 |
| 2026-09-15 | quarter | 2027-12-31 | $-0.34 | $-6.90 | ▼ 6.56 | $1,704,500 | $1,704,500 |
| 2026-09-15 | annual | 2030-12-31 | $0.93 | $18.60 | ▲ 17.67 | $162,500,000 | $162,500,000 |
| 2026-09-15 | annual | 2026-12-31 | $-0.38 | $-7.60 | ▼ 7.22 | $714,067 | $714,067 |
| 2026-09-15 | quarter | 2026-06-30 | $-0.20 | $-3.90 | ▼ 3.70 | $267,800 | $267,800 |
| 2026-09-15 | quarter | 2027-09-30 | $-0.05 | $-0.97 | ▼ 0.92 | $1,639,000 | $1,639,000 |
| 2026-09-15 | quarter | 2026-09-30 | $-0.04 | $-0.79 | ▼ 0.75 | $535,600 | $535,600 |
| 2026-09-15 | annual | 2029-12-31 | $0.45 | $9.00 | ▲ 8.55 | $21,400,000 | $21,400,000 |
Earnings Call Transcripts
No transcripts available.